Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

by | Jan 30, 2026 | news, Top News

The plant will help make Lilly’s experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage trial. 

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments